ResearchMoz

Browse reports in Pharmaceutical

Displaying 1 to 30 (of 8472 records)
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
Oct 2014   |   By - GlobalData
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023 Summary Dyslipidemia is a condition in which one or more of the serum lipid levels are abnormal. It is a well-established risk factor for cardiovascular disease, and the burden of morbidity, mortality, and medical costs arising from dyslipidemia is substantial. GlobalData epidemiologists forecast that the total prevalent cases of...
$3995
Pharmaceutical Business Confidence Report Q3 2014
Oct 2014   |   By - Kable Market Research
Pharmaceutical Business Confidence Report Q3 2014” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry. This report also examines executive opinion with regards to the current and future state of the economy and its retrospective...
$1950
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
Oct 2014   |   By - GlobalData
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In allergic conjunctivitis, the conjunctiva - a layer of tissue which lines the front part of the eyeball (the white part of...
$3995
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014
Oct 2014   |   By - GlobalData
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...
$2500
Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics
Oct 2014   |   By - Current Partnering
The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies.   This new 1st edition, includes:   Trends in joint venture deals Joint venture agreement structure Joint venture...
$1995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel
Oct 2014   |   By - GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel Summary GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key...
$1995
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014" provides data on the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) clinical trial scenario. This report provides elemental information and data relating to the...
$2500
Thrombosis Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Thrombosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of...
$2500
Unstable Angina Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Unstable Angina Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Unstable Angina Global Clinical Trials Review, H2, 2014" provides data on the Unstable Angina clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Unstable Angina. It includes an overview of the trial numbers and their recruitment...
$2500
Vascular Calcification Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Vascular Calcification Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Vascular Calcification Global Clinical Trials Review, H2, 2014" provides data on the Vascular Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vascular Calcification. It includes an overview of the trial numbers...
$2500
Vasospastic Angina Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Vasospastic Angina Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Vasospastic Angina Global Clinical Trials Review, H2, 2014" provides data on the Vasospastic Angina clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vasospastic Angina. It includes an overview of the trial numbers and their...
$2500
Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Venous (Vein) Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous (Vein) Thrombosis. It includes an overview of the trial...
$2500
Ventricular Septal Defect Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Ventricular Septal Defect Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Ventricular Septal Defect Global Clinical Trials Review, H2, 2014" provides data on the Ventricular Septal Defect clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Septal Defect. It includes an overview of the...
$2500
Anca Vasculitis Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Anca Vasculitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Anca Vasculitis Global Clinical Trials Review, H2, 2014" provides data on the Anca Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anca Vasculitis. It includes an overview of the trial numbers and their recruitment...
$2500
Axial Spondyloarthritis Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Axial Spondyloarthritis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Axial Spondyloarthritis Global Clinical Trials Review, H2, 2014" provides data on the Axial Spondyloarthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Axial Spondyloarthritis. It includes an overview of the trial...
$2500
Behcet's Disease Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Behcet's Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Behcet's Disease Global Clinical Trials Review, H2, 2014" provides data on the Behcets Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Behcets Disease. It includes an overview of the trial numbers and their recruitment...
$2500
Birch Pollen Allergy Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Birch Pollen Allergy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Birch Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Birch Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Birch Pollen Allergy. It includes an overview of the trial numbers and...
$2500
Cat Allergy Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Cat Allergy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Cat Allergy Global Clinical Trials Review, H2, 2014" provides data on the Cat Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cat Allergy. It includes an overview of the trial numbers and their recruitment status as per the...
$2500
Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Cedar Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cedar Pollen Allergy. It includes an overview of the trial numbers and...
$2500
Behcet's Disease Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Behcet's Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Behcet's Disease Global Clinical Trials Review, H2, 2014" provides data on the Behcets Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Behcets Disease. It includes an overview of the trial numbers and their recruitment...
$2500
Global and China Water-Based Antioxidant Industry 2014 Market Research Report
Sep 2014   |   By - QYResearch
The report firstly introduced Water-based antioxidant basic information included Water-based antioxidant definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Water-based antioxidant industry policy and plan, Water-based...
$2200
Global N-acetylcysteine Industry 2014 Market Research Report
Sep 2014   |   By - QYResearch
The report firstly introduced N-acetylcysteine basic information included N-acetylcysteine definition classification application industry chain structure industry overview; Then introduce North America (United States Canada Mexico etc) Europe (Germany France United Kingdom Italy Spain etc) Asia (China Japan India Korea etc) Rest of World (Australia South America Middle East and Africa...
$3600
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023
Sep 2014   |   By - GlobalData
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of...
$4995
PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023
Sep 2014   |   By - GlobalData
n the neoadjuvant setting, in particular, Perjeta, which is already approved for use in this setting in the US. Scope - An overview of HER2-Positive Breast Cancer, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the 5EU HER2-Positive Breast Cancer market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. -...
$6995
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023
Sep 2014   |   By - GlobalData
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of...
$4995
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023
Sep 2014   |   By - GlobalData
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of...
$4995
Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014" provides data on the Fibrinogen Deficiency (Factor I Deficiency) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...
$2500
Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
Sep 2014   |   By - GlobalData
Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current...
$3495
Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014
Sep 2014   |   By - GlobalData
Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014" provides data on the Peripheral Artery Occlusive Disease (PAOD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...
$2500
Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
Sep 2014   |   By - GlobalData
Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023. HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current...
$3495
 
Displaying 1 to 30 (of 8472 records)

Pharmaceutical Market Research Reports & Industry Analysis

Since the beginning of the 19th Century, the pharmaceutical industry is recognized as one of the most successful and influential industries in the field of medicine and pharmacy. This industry has come a long way from R&D to the point of sale, exceedingly gaining the attention and business of major companies abreast to manufacturing, yielding, and innovating new drugs and novel medical products for the betterment and future of the society. 

Pharmaceutical industry is all about a commercial business that focuses on research, development, marketing generic drugs and/or distributing drugs in the context of healthcare. This industry deals in generic and brand medications as well. Pharmaceutical sector has increased due to factors like government and private spending on healthcare infrastructure, low drug penetration, disposable income, and increasing medical insurance penetration.

The pharmaceutical industry is enhanced due to pharmaceutical market research, and in its entire journey, it has experienced both praise and controversy.

This industry has seen rapid progress in terms of technology base, infrastructure development, and a wide gamut of products that are manufactured in the market.

Furthermore, it has been in huge demand also because of the rapid development of the drugs and capability of cost-effective medicines with world class manufacturing facilities.
Today, the global pharmaceuticals market is valued to be at US$300 billion a year and is further expected to rise to US$400 billion in the next three years. The fact remains that pharmaceutical products rarely sell themselves, and therefore, market research is essential to ensure several companies have their strategies and tactics set up in an appropriate way. This will help them develop and market their products well.

ResearchMoz helps you make the right market decisions you need in the pharmaceutical market research. Our reports are an access to proprietary tools for pharmaceutical market research, decision modeling and analytics. They are grounded in reality and designed for action. 
Pharmaceutical

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData